Category: Featured
-
Dual pathway inhibition with faricimab for previously treated neovascular age-related macular degeneration and diabetic macular oedema: guidance from a UK panel of retina specialists
Standard of care for the treatment of neovascular age-related macular degeneration (nAMD) and visual impairment due to centre-involving diabetic macular oedema (DMO) is intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy [1, 2]. Anti-VEGF treatment offers significant visual and anatomic benefits in most patients with nAMD and DMO [1,2,3]. However, frequent anti-VEGF injections are often needed to…
-
Recurrent retinal detachment in Stickler Syndrome
Stickler Syndrome is the most common inherited cause of rhegmatogenous retinal detachments (RD) [1]. It is a collagen disorder identified by the ocular manifestations of abnormal vitreous development and unusually high myopia, with systemic findings of craniofacial abnormalities, hearing loss, and arthropathy [2]. Approximately 40–60% of patients with Stickler Syndrome will develop a rhegmatogenous RD…